Acrivon Therapeutics, Inc. Common Stock (ACRV) — Financial Flexibility Index
Acrivon Therapeutics, Inc. Common Stock (ACRV) has a Financial Flexibility Index of -0.68x as of September 2025. Free cash flow of $-11.38 Million (operating CF $-12.28 Million minus capex $899.00K) represents -1% of total liabilities ($16.70 Million). Check Acrivon Therapeutics, Inc. Common Stock tangible equity quality to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Acrivon Therapeutics, Inc. Common Stock Financial Flexibility Index (2020–2024)
Historical Financial Flexibility Index trend for Acrivon Therapeutics, Inc. Common Stock across 5 annual periods. For the full cash flow conversion analysis, see ACRV cash flow conversion.
Annual Financial Flexibility Index for Acrivon Therapeutics, Inc. Common Stock (2020–2024)
Year-by-year free cash flow to debt coverage for Acrivon Therapeutics, Inc. Common Stock. Explore Acrivon Therapeutics, Inc. Common Stock cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.18x | $-62.90 Million | $-65.67 Million | $19.80 Million | ▼ -31.1% |
| 2023 | -2.42x | $-41.35 Million | $-42.64 Million | $17.07 Million | ▲ +6.8% |
| 2022 | -2.60x | $-27.95 Million | $-30.12 Million | $10.75 Million | ▼ -2366.6% |
| 2021 | -0.11x | $-13.74 Million | $-13.98 Million | $130.40 Million | ▲ +59.9% |
| 2020 | -0.26x | $-2.79 Million | $-2.80 Million | $10.60 Million | — |